Z-0218-2019 Class II Terminated

Recalled by BioMerieux SA — Marcy L'Etoile, N/A

FDA device recall Z-0218-2019 was initiated by BioMerieux SA on Sep 17, 2018 and is designated Class II. Reason for recall: Data loggers showed that one shipment to the United States experienced low temperatures that may impact performance of this product. The recall status is terminated (terminated May 18, 2020). Affected quantity: 42 units.

Recall Details

Product Type
Devices
Report Date
Oct 31, 2018
Initiation Date
Sep 17, 2018
Termination Date
May 18, 2020
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
42 units

Product Description

NucliSENS¿ Magnetic Extraction Reagents

Reason for Recall

Data loggers showed that one shipment to the United States experienced low temperatures that may impact performance of this product.

Distribution Pattern

Nationwide distribution to MD, TX, MA, GA, OH, OR, CA, and WA.

Code Information

Reference # 200293, Lot # 17121501, Expiration date 11/28/2018

Source

Dataset
openFDA device recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for Z-0218-2019
openFDA file date
Oct 23, 2026
Loaded by RegDataLab
Oct 24, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.